Wealth Enhancement Advisory Services, LLC Verrica Pharmaceuticals Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,133 shares of VRCA stock, worth $80,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,133Holding current value
$80,557% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRCA
# of Institutions
80Shares Held
22.4MCall Options Held
2.3KPut Options Held
5.1K-
Armistice Capital, LLC New York, NY8.92MShares$70.9 Million1.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.25MShares$25.8 Million0.86% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.59MShares$20.6 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$14.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...